ScandiBio Therapeutics
PrivateLast Round
Early Funding
Nov 1, 2025
Company Overview
ScandiBio Therapeutics is a biotechnology company that develops AI-driven pharmaceutical drugs targeting mitochondrial dysfunction for the treatment of metabolic and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ScandiBio Therapeutics Comparables
Compare ScandiBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vandria | 82% | |
| OrsoBio | 66% | |
| Think Bioscience | 63% | |
ScandiBio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 1, 2025 | ||||
| Seed | Jan 1, 2018 |
ScandiBio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Early Funding, Seed |
ScandiBio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ScandiBio Therapeutics's valuation, stock price, and market status.